Skip to main content

Joan Gavaldà Santapau

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Joan Gavaldà Santapau

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Projects

ThermoShot /FlashShot: a New Technology against Antimicrobial Resistant and Biofilm Infections

IP: Joan Gavaldà Santapau
Collaborators: -
Funding agency: Fundació "La Caixa"
Funding: 70000
Reference: CI17-00071
Duration: 20/11/2017 - 20/11/2018

thermo/Flashshot: una nueva tecnologia cintra infecciones por bacterias resistentes a astimicrobianos y biofilms

IP: Joan Gavaldà Santapau
Collaborators: -
Funding agency: Fundación Innov. y Prosp. Salud en España - FIPSE
Funding: 30000
Reference: FIPSE/VIABILITAT/2017/JOAN GAVALDÀ
Duration: 07/02/2018 - 06/08/2018

ThermoShot /FlashShot: a New Technology against Antimicrobial Resistant and Biofilm Infections

IP: Joan Gavaldà Santapau
Collaborators: -
Funding agency: CERCA (Centres de Recerca de Catalunya)
Funding: 10000
Reference: CERCA/GÍNJOL/2017/GAVALDA
Duration: 01/01/2016 - 31/12/2017

Incorporació Dr. Benito Almirante a la RETICS en malalties infeccioses RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS

IP: -
Collaborators: María Nieves Larrosa Escartin, Oscar Len Abad, Gema Codina Grau, Mª Carmen Ferrer Barberà, Andres Antón Pagarolas, Rosa María Bartolomé Comas, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juliana Esperalba Esquerra, Ma Dolores Rodríguez Pardo, Alba Mir Cros, Julia Sellares Nadal, Tomàs Pumarola Suñé, Carles Pigrau Serrallach, Isabel Ruiz Camps, Mayli Lung Suarez, Mª Teresa Tórtola Fernández, Juan Jose Gonzalez Lopez, Pablo Salvador Corona Pérez-Cardona, Ibai Los Arcos Bertiz
Funding agency: Instituto de Salud Carlos III
Funding: 401918
Reference: RD16/0016/0003
Duration: 01/01/2017 - 31/12/2022

Related news

All patients showed a favorable clinical course and responded well to antibiotic treatment, without complications.

The study results show that the local presence of IL-1β promotes the development of myeloid cells with an immunosuppressive function.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Related professionals

Lara Urbistondo Sans

Lara Urbistondo Sans

Gestió i Administració
Unitat legal
Legal Directorate
Read more
Belen Perez Gomez

Belen Perez Gomez

Predoctoral researcher
Multidisciplinary Nursing Research Group
Read more
Fernando Moreno Flores

Fernando Moreno Flores

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Nina Borràs Agustí

Nina Borràs Agustí

Postdoctoral researcher
Transfusional Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.